Randomised, double-blind trial of dual add-on saxagliptin plus dapagliflozin vs saxagliptin or dapagliflozin add-on alone in poorly controlled type 2 diabetes on metformin

被引：0
|
作者：
Hansen, L. [1 ]
Zee, P. [1 ]
Li, Y. [2 ]
Cook, W. [2 ]
Hirshberg, B. [2 ]
Iqbal, N. [1 ]
Rosenstock, J. [3 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] AstraZeneca, Wilmington, DE USA
[3] Dallas Diabet & Endocrine Ctr, Dallas, TX USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] A randomised, double-blind trial of saxagliptin add-on to dapagliflozin plus metformin
    Catrinoiu, D.
    Matthaei, S.
    Celinski, A.
    Ekholm, E.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Hansen, L.
    [J]. DIABETOLOGIA, 2015, 58 : S386 - S386
  • [2] A Randomized, Double-Blind Trial of Saxagliptin Add-on to Dapagliflozin plus Metformin
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    Hansen, Lars
    [J]. DIABETES, 2015, 64 : A27 - A28
  • [3] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    [J]. DIABETES, 2018, 67
  • [4] A randomised, double-blind phase 3 trial of dapagliflozin add-on to saxagliptin plus metformin in type 2 diabetes
    Mathieu, C.
    Ranetti, A. E.
    Li, D.
    Ekholm, E.
    Cook, W.
    Hirshberg, B.
    Hansen, L.
    Iqbal, N.
    [J]. DIABETOLOGIA, 2015, 58 : S356 - S356
  • [5] Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
    Rosenstock, Julio
    Hansen, Lars
    Zee, Pamela
    Li, Yan
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    [J]. DIABETES CARE, 2015, 38 (03) : 376 - 383
  • [6] A Randomized, Double-Blind, Phase 3 Trial of Dapagliflozin Add-on to Saxagliptin plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian E.
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Hansen, Lars
    Iqbal, Nayyar
    [J]. DIABETES, 2015, 64 : A28 - A28
  • [7] Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Iqbal, Nayyar
    Hansen, Lars
    [J]. DIABETES CARE, 2015, 38 (11) : 2018 - 2024
  • [8] Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian Emil
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Hansen, Lars
    Iqbal, Nayyar
    [J]. DIABETES CARE, 2015, 38 (11) : 2009 - 2017
  • [9] Triple therapy with saxagliptin and dapagliflozin add-on to metformin: safety of dual add-on versus sequential add-on
    Garcia-Sanchez, R.
    Del Prato, S.
    Matthaei, S.
    Iqbal, N.
    Hansen, L.
    Johnsson, E.
    Chen, H.
    Chin, A. J.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2015, 58 : S356 - S356
  • [10] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
12345